Hayam AlRasheed | Telepharmacy | Innovative Research Award

Innovative Research Award

Hayam AlRasheed

Princess Nourah University, Saudi Arabia

Hayam AlRasheed
Affiliation Princess Nourah University
Country Saudi Arabia
Scopus ID 58411797200
Documents 49
Citations 224
h-index 8
Subject Area Telepharmacy
Event International Popular Scientist Awards
ORCID 0009-0002-6186-848X

Hayam AlRasheed the Innovative Research Award recognizes scholarly contributions that demonstrate sustained academic engagement, measurable research visibility, and emerging influence in interdisciplinary healthcare studies. Hayam AlRasheed of Princess Nourah University has contributed to the field of telepharmacy through research activities that support healthcare accessibility, patient communication systems, and digital pharmaceutical services within modern healthcare environments.[1] The recognition is associated with the International Popular Scientist Awards, which acknowledge researchers contributing to evidence-based innovation and academic advancement.[4]

Abstract

This academic recognition article documents the scholarly profile and research activities of Hayam AlRasheed, a researcher affiliated with Princess Nourah University in Saudi Arabia. The article highlights research productivity indexed through Scopus metrics, interdisciplinary engagement in telepharmacy-related healthcare innovation, and contributions toward pharmaceutical communication and digital healthcare accessibility.[1] The recognition aligns with the objectives of the International Popular Scientist Awards, which emphasize scientific visibility, academic integrity, and evidence-driven research contributions in emerging fields of healthcare services.[4]

Keywords

Telepharmacy, Digital Healthcare, Pharmaceutical Services, Healthcare Communication, Clinical Pharmacy, Research Visibility, Scopus Indexing, Healthcare Innovation, Academic Recognition, Saudi Arabia.

Introduction

Telepharmacy has emerged as an important component of modern healthcare systems, particularly in improving pharmaceutical access, patient consultation mechanisms, and remote healthcare support services.[2] Researchers working in this domain contribute to the integration of communication technologies with pharmacy practice to improve patient outcomes and healthcare delivery models.[3]

Hayam AlRasheed has participated in scholarly activities associated with telepharmacy and healthcare innovation while contributing to academic research visibility through indexed publications and interdisciplinary collaboration. Her work reflects the broader transition toward digital healthcare ecosystems that support efficient pharmaceutical practices and evidence-based healthcare communication strategies.[1]

Research Profile

The research profile of Hayam AlRasheed demonstrates scholarly engagement within healthcare-related research environments, particularly in telepharmacy and pharmaceutical communication studies. Indexed academic metrics indicate publication activity, citation performance, and sustained participation in peer-reviewed scientific literature.[1]

Research Contributions

Research contributions associated with telepharmacy often involve improving patient-centered pharmaceutical services, remote consultation systems, medication accessibility, and healthcare communication practices.[2] Scholarly work in this domain supports healthcare modernization through digital integration and evidence-based healthcare delivery approaches.[3]

Hayam AlRasheed’s academic profile reflects engagement with healthcare innovation themes relevant to pharmaceutical service optimization and interdisciplinary healthcare studies. Such research contributes to ongoing discussions regarding digital healthcare transformation and pharmaceutical accessibility within clinical and community healthcare systems.[5]

Publications

The publication record indexed within international academic databases reflects continued scholarly activity and participation in peer-reviewed scientific communication. Indexed publications contribute to research visibility and facilitate academic collaboration across healthcare and pharmaceutical sciences.[1]

Research Impact

Research impact is commonly evaluated through citation indicators, publication indexing, scholarly engagement, and interdisciplinary applicability. The available Scopus metrics associated with Hayam AlRasheed indicate measurable academic visibility within healthcare-related scientific literature.[1]

The evolving role of telepharmacy in healthcare systems highlights the importance of research addressing healthcare accessibility, remote pharmaceutical consultation, and digital patient support. Contributions in these areas may support healthcare institutions, policy discussions, and future research initiatives focused on digital healthcare transformation.[2]

Award Suitability

The Innovative Research Award emphasizes scholarly excellence, research visibility, interdisciplinary relevance, and measurable contribution to scientific advancement. Hayam AlRasheed’s academic profile demonstrates alignment with these criteria through publication activity, healthcare-related research engagement, and indexed scholarly impact.[1]

Participation in telepharmacy research and healthcare innovation initiatives further supports the suitability of this recognition within the context of contemporary healthcare transformation and evidence-based digital healthcare services.[3]

Conclusion

The academic profile of Hayam AlRasheed reflects sustained scholarly engagement in telepharmacy and healthcare innovation research. Through indexed publications, interdisciplinary participation, and measurable citation metrics, the researcher contributes to ongoing developments in digital healthcare and pharmaceutical communication systems.[1] The Innovative Research Award within the International Popular Scientist Awards framework recognizes these contributions as part of broader efforts to encourage evidence-based scientific advancement and healthcare innovation.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Hayam AlRasheed, Author ID 58411797200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58411797200
  2. Alexander, E., Butler, C. D., Darr, A., Jenkins, M. T., Long, R. D., Shipman, C. J., & Stratton, T. P. (2017). ASHP statement on telepharmacy. American Journal of Health-System Pharmacy, 74(9), e236-e241.
    DOI: https://doi.org/10.2146/ajhp170039
  3. Poudel, A., Nissen, L. M., & others. (2016). Telepharmacy: A pharmacist’s perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice, 5, 75-82.
    DOI:https://doi.org/10.2147/IPRP.S101685
  4. International Popular Scientist Awards. (n.d.). Official award and recognition platform.
    https://popularscientist.com/
  5. World Health Organization. (2021). Global strategy on digital health 2020–2025. WHO Publications.
    https://www.who.int/publications/i/item/9789240020924

Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Dr. Xu jiancheng | Medicine and Health Sciences | Best Researcher Award

Professor First Hospital of Jilin University China

Professor Jiancheng Xu (MD, PhD) is a distinguished clinical microbiologist with over 20 years of experience in laboratory medicine. He currently serves as Professor, Doctoral Supervisor, and Deputy Director of the Department of Laboratory Medicine at the First Hospital of Jilin University, China. A joint-training PhD scholar from the University of Louisville, USA, he has made significant contributions to microbiology, diabetic complications, and laboratory diagnostics. He is also a reviewer for several international journals and an influential figure in multiple national medical associations. Outside the lab, he enjoys running and badminton. 🏃‍♂️🏸

Profile

Orcid

🎓 Education

Professor Xu’s academic path reflects a commitment to excellence. He earned his MD from Norman Bethune University of Medical Sciences (1995–2000), followed by an MS in Laboratory Medicine and a PhD in Internal Medicine from Jilin University (2002–2010). He undertook a joint PhD program at the University of Louisville (2008–2009), enhancing his global research exposure. He further completed a postdoctoral fellowship in Laboratory Medicine at China Medical University (2012–2016), solidifying his scientific and clinical foundation. 🎓🧪

💼 Professional Experience

Professor Xu has advanced steadily through academic and clinical ranks. Beginning as a Research Assistant (2000–2006), he became an Attending Physician (2006–2010), Associate Professor (2010–2014), and finally Professor in 2014 at the First Hospital of Jilin University. He currently serves as the Deputy Director of the Department of Laboratory Medicine, mentoring numerous doctoral candidates and leading transformative research. 🧑‍🏫🏥

🔬 Research Interests

Professor Xu’s research spans across vital domains:

  1. 🧠 Mechanism of Diabetic Complications

  2. 🦠 Bacterial Resistance Mechanisms and Surveillance

  3. 📊 Establishment of Reference Intervals for Clinical Tests

  4. 🤖 Disease Prediction Modeling with Machine Learning

  5. 🧬 Trace Element Metabolism in Diabetic Models

His work integrates clinical insights with computational analytics to develop predictive tools and diagnostic advancements in laboratory medicine.

🏆 Awards & Honors

Professor Xu’s outstanding contributions have earned him numerous accolades and appointments:

  • 🏅 Chairman, Society of Laboratory Medicine, Jilin Medical Security Association

  • 🏅 Vice Chairman, Youth Committee, Chinese Society of Laboratory Medicine

  • 🏅 Vice Chairman, Youth Committee, Jilin Medical Association

  • 🏅 Member, Standing Committees across multiple national and provincial laboratory medicine societies

  • 📚 Editorial Board Member, Chinese Journal of Laboratory Medicine

  • 🧪 Reviewer for Biological Trace Element Research, OMICS, and others

He has successfully led over 33 funded research projects, totaling ¥7.04 million RMB.

📚 Publications Top Notes: 

Professor Xu has authored over 125 peer-reviewed articles, with an H-index of 16 and over 1269 citations. His top publications as a corresponding author include:

🧬 A Prognostic Model to Predict Recovery of COVID-19 Patients Based on Longitudinal Laboratory Findings
Virologica Sinica, 2020 – Cited by 39 articles

🧫 The Function of T Follicular Helper Cells in the Autoimmune Liver Diseases
Journal of Immunology Research, 2020 – Cited by 27 articles

🧪 Negative Results in Nucleic Acid Test of COVID-19 Patients: Assessment from Clinical Laboratories
Annals of Palliative Medicine, 2020 – Cited by 18 articles

⚖️ Age- and Sex-Specific Pediatric Reference Intervals of Serum Electrolytes
American Journal of Clinical Pathology, 2020 – Cited by 21 articles

🧫 Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2
Health Security, 2020 – Cited by 14 articles

❤️ Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in COVID-19
BioMed Research International, 2020 – Cited by 33 articles

Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation